nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ABCB1—adrenal gland cancer	0.56	1	CbGaD
Imatinib—Nilotinib—BRAF—adrenal gland cancer	0.00768	0.697	CrCbGaD
Imatinib—DDR1—adrenal cortex—adrenal gland cancer	0.00598	0.0386	CbGeAlD
Imatinib—HIPK4—gonad—adrenal gland cancer	0.00542	0.035	CbGeAlD
Imatinib—CYP2C19—urine—adrenal gland cancer	0.00528	0.0341	CbGeAlD
Imatinib—ABCA3—pituitary gland—adrenal gland cancer	0.00523	0.0338	CbGeAlD
Imatinib—DDR1—cardiac atrium—adrenal gland cancer	0.00494	0.0319	CbGeAlD
Imatinib—DDR1—pituitary gland—adrenal gland cancer	0.00483	0.0312	CbGeAlD
Imatinib—ABCA3—adrenal gland—adrenal gland cancer	0.00468	0.0302	CbGeAlD
Imatinib—DDR1—adrenal gland—adrenal gland cancer	0.00431	0.0278	CbGeAlD
Imatinib—CYP1A2—urine—adrenal gland cancer	0.00431	0.0278	CbGeAlD
Imatinib—CYP2C9—urine—adrenal gland cancer	0.00409	0.0264	CbGeAlD
Imatinib—PIP4K2C—adrenal cortex—adrenal gland cancer	0.00369	0.0238	CbGeAlD
Imatinib—ABL2—pituitary gland—adrenal gland cancer	0.00315	0.0203	CbGeAlD
Imatinib—CYP3A4—urine—adrenal gland cancer	0.00312	0.0201	CbGeAlD
Imatinib—CYP2D6—urine—adrenal gland cancer	0.00307	0.0198	CbGeAlD
Imatinib—PIP4K2C—gonad—adrenal gland cancer	0.00306	0.0197	CbGeAlD
Imatinib—PIP4K2C—cardiac atrium—adrenal gland cancer	0.00305	0.0197	CbGeAlD
Imatinib—PIP4K2C—pituitary gland—adrenal gland cancer	0.00298	0.0192	CbGeAlD
Imatinib—CA3—cardiac atrium—adrenal gland cancer	0.00291	0.0188	CbGeAlD
Imatinib—CA3—pituitary gland—adrenal gland cancer	0.00285	0.0184	CbGeAlD
Imatinib—ABL2—adrenal gland—adrenal gland cancer	0.00281	0.0182	CbGeAlD
Imatinib—NQO2—adrenal cortex—adrenal gland cancer	0.00271	0.0175	CbGeAlD
Imatinib—PIP4K2C—adrenal gland—adrenal gland cancer	0.00266	0.0172	CbGeAlD
Imatinib—CA14—cardiac atrium—adrenal gland cancer	0.00265	0.0171	CbGeAlD
Imatinib—CSF1R—adrenal cortex—adrenal gland cancer	0.00238	0.0154	CbGeAlD
Imatinib—LCK—adrenal gland—adrenal gland cancer	0.00236	0.0153	CbGeAlD
Imatinib—CA14—adrenal gland—adrenal gland cancer	0.00231	0.0149	CbGeAlD
Imatinib—NQO2—cardiac atrium—adrenal gland cancer	0.00224	0.0145	CbGeAlD
Imatinib—PDGFRA—gonad—adrenal gland cancer	0.00224	0.0144	CbGeAlD
Imatinib—NQO2—pituitary gland—adrenal gland cancer	0.00219	0.0141	CbGeAlD
Imatinib—SLC47A1—adrenal cortex—adrenal gland cancer	0.00217	0.014	CbGeAlD
Imatinib—PDGFRB—adrenal cortex—adrenal gland cancer	0.00211	0.0136	CbGeAlD
Imatinib—CSF1R—gonad—adrenal gland cancer	0.00197	0.0127	CbGeAlD
Imatinib—CSF1R—cardiac atrium—adrenal gland cancer	0.00197	0.0127	CbGeAlD
Imatinib—NQO2—adrenal gland—adrenal gland cancer	0.00196	0.0126	CbGeAlD
Imatinib—PDGFRA—adrenal gland—adrenal gland cancer	0.00195	0.0126	CbGeAlD
Imatinib—Ponatinib—ABCB1—adrenal gland cancer	0.00193	0.175	CrCbGaD
Imatinib—CSF1R—pituitary gland—adrenal gland cancer	0.00192	0.0124	CbGeAlD
Imatinib—ABL1—adrenal cortex—adrenal gland cancer	0.00188	0.0121	CbGeAlD
Imatinib—SLC47A1—gonad—adrenal gland cancer	0.0018	0.0116	CbGeAlD
Imatinib—KIT—gonad—adrenal gland cancer	0.00179	0.0116	CbGeAlD
Imatinib—SLC47A1—pituitary gland—adrenal gland cancer	0.00176	0.0113	CbGeAlD
Imatinib—PDGFRB—gonad—adrenal gland cancer	0.00175	0.0113	CbGeAlD
Imatinib—KIT—pituitary gland—adrenal gland cancer	0.00175	0.0113	CbGeAlD
Imatinib—PDGFRB—cardiac atrium—adrenal gland cancer	0.00175	0.0113	CbGeAlD
Imatinib—CSF1R—adrenal gland—adrenal gland cancer	0.00172	0.0111	CbGeAlD
Imatinib—PDGFRB—pituitary gland—adrenal gland cancer	0.00171	0.011	CbGeAlD
Imatinib—SLC47A1—adrenal gland—adrenal gland cancer	0.00157	0.0101	CbGeAlD
Imatinib—KIT—adrenal gland—adrenal gland cancer	0.00156	0.0101	CbGeAlD
Imatinib—ABL1—gonad—adrenal gland cancer	0.00156	0.0101	CbGeAlD
Imatinib—ABL1—cardiac atrium—adrenal gland cancer	0.00156	0.01	CbGeAlD
Imatinib—PDGFRB—adrenal gland—adrenal gland cancer	0.00152	0.00983	CbGeAlD
Imatinib—ABL1—pituitary gland—adrenal gland cancer	0.00152	0.00981	CbGeAlD
Imatinib—Nilotinib—ABCB1—adrenal gland cancer	0.00142	0.129	CrCbGaD
Imatinib—ABL1—adrenal gland—adrenal gland cancer	0.00136	0.00876	CbGeAlD
Imatinib—CA2—adrenal cortex—adrenal gland cancer	0.00128	0.00827	CbGeAlD
Imatinib—ALB—adrenal gland—adrenal gland cancer	0.00125	0.00809	CbGeAlD
Imatinib—ABCG2—adrenal cortex—adrenal gland cancer	0.00119	0.00766	CbGeAlD
Imatinib—CA2—cardiac atrium—adrenal gland cancer	0.00106	0.00684	CbGeAlD
Imatinib—CA2—pituitary gland—adrenal gland cancer	0.00103	0.00668	CbGeAlD
Imatinib—ABCG2—pituitary gland—adrenal gland cancer	0.000958	0.00619	CbGeAlD
Imatinib—CA2—adrenal gland—adrenal gland cancer	0.000925	0.00597	CbGeAlD
Imatinib—ABCG2—adrenal gland—adrenal gland cancer	0.000856	0.00553	CbGeAlD
Imatinib—PTGS1—cardiac atrium—adrenal gland cancer	0.000818	0.00528	CbGeAlD
Imatinib—PTGS1—pituitary gland—adrenal gland cancer	0.000799	0.00516	CbGeAlD
Imatinib—PTGS1—adrenal gland—adrenal gland cancer	0.000714	0.00461	CbGeAlD
Imatinib—ABCB1—adrenal cortex—adrenal gland cancer	0.000585	0.00378	CbGeAlD
Imatinib—ABCB1—gonad—adrenal gland cancer	0.000484	0.00313	CbGeAlD
Imatinib—ABCB1—pituitary gland—adrenal gland cancer	0.000473	0.00305	CbGeAlD
Imatinib—ABCB1—adrenal gland—adrenal gland cancer	0.000422	0.00273	CbGeAlD
Imatinib—LCK—Signaling Pathways—GNRH1—adrenal gland cancer	5.8e-05	0.000212	CbGpPWpGaD
Imatinib—CA12—Metabolism—PTGS2—adrenal gland cancer	5.75e-05	0.00021	CbGpPWpGaD
Imatinib—LCK—Immune System—PRKACA—adrenal gland cancer	5.74e-05	0.00021	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.71e-05	0.000209	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.67e-05	0.000207	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SDHD—adrenal gland cancer	5.67e-05	0.000207	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—RRM1—adrenal gland cancer	5.67e-05	0.000207	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MED12—adrenal gland cancer	5.66e-05	0.000207	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CTNNB1—adrenal gland cancer	5.61e-05	0.000205	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—BAD—adrenal gland cancer	5.6e-05	0.000204	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CDC42—adrenal gland cancer	5.6e-05	0.000204	CbGpPWpGaD
Imatinib—ALB—Hemostasis—CDC42—adrenal gland cancer	5.55e-05	0.000203	CbGpPWpGaD
Imatinib—CA2—Metabolism—POMC—adrenal gland cancer	5.51e-05	0.000201	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.44e-05	0.000199	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MED12—adrenal gland cancer	5.44e-05	0.000198	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PRKACA—adrenal gland cancer	5.42e-05	0.000198	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IGF2—adrenal gland cancer	5.35e-05	0.000195	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.35e-05	0.000195	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—EGFR—adrenal gland cancer	5.33e-05	0.000195	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CTNNB1—adrenal gland cancer	5.31e-05	0.000194	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SPRY2—adrenal gland cancer	5.31e-05	0.000194	CbGpPWpGaD
Imatinib—ALB—Hemostasis—GNAS—adrenal gland cancer	5.3e-05	0.000194	CbGpPWpGaD
Imatinib—LCK—Disease—PRKACA—adrenal gland cancer	5.3e-05	0.000193	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SDHB—adrenal gland cancer	5.3e-05	0.000193	CbGpPWpGaD
Imatinib—CA1—Metabolism—POMC—adrenal gland cancer	5.28e-05	0.000193	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—CTNNB1—adrenal gland cancer	5.28e-05	0.000193	CbGpPWpGaD
Imatinib—KIT—Disease—TERT—adrenal gland cancer	5.27e-05	0.000192	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TSHR—adrenal gland cancer	5.17e-05	0.000189	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PRKACA—adrenal gland cancer	5.13e-05	0.000187	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.06e-05	0.000185	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TERT—adrenal gland cancer	5.04e-05	0.000184	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TERT—adrenal gland cancer	4.99e-05	0.000182	CbGpPWpGaD
Imatinib—KIT—Immune System—BAD—adrenal gland cancer	4.97e-05	0.000181	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.96e-05	0.000181	CbGpPWpGaD
Imatinib—ALB—Metabolism—SDHD—adrenal gland cancer	4.88e-05	0.000178	CbGpPWpGaD
Imatinib—ALB—Metabolism—RRM1—adrenal gland cancer	4.88e-05	0.000178	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.88e-05	0.000178	CbGpPWpGaD
Imatinib—LCK—Immune System—CDC42—adrenal gland cancer	4.87e-05	0.000178	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.87e-05	0.000178	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MEN1—adrenal gland cancer	4.86e-05	0.000177	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CTNNB1—adrenal gland cancer	4.78e-05	0.000175	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—BAD—adrenal gland cancer	4.7e-05	0.000172	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CTNNB1—adrenal gland cancer	4.66e-05	0.00017	CbGpPWpGaD
Imatinib—CA9—Metabolism—POMC—adrenal gland cancer	4.64e-05	0.000169	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PRKACA—adrenal gland cancer	4.63e-05	0.000169	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CDC42—adrenal gland cancer	4.6e-05	0.000168	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.59e-05	0.000168	CbGpPWpGaD
Imatinib—KIT—Disease—BAD—adrenal gland cancer	4.59e-05	0.000167	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	4.57e-05	0.000167	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	4.51e-05	0.000164	CbGpPWpGaD
Imatinib—LCK—Disease—CDC42—adrenal gland cancer	4.5e-05	0.000164	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TERT—adrenal gland cancer	4.49e-05	0.000164	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—EGFR—adrenal gland cancer	4.44e-05	0.000162	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IGF2—adrenal gland cancer	4.43e-05	0.000162	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—GNAS—adrenal gland cancer	4.4e-05	0.00016	CbGpPWpGaD
Imatinib—CA2—Metabolism—PTGS2—adrenal gland cancer	4.39e-05	0.00016	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—BAD—adrenal gland cancer	4.38e-05	0.00016	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—RRM1—adrenal gland cancer	4.38e-05	0.00016	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SDHD—adrenal gland cancer	4.38e-05	0.00016	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CDC42—adrenal gland cancer	4.36e-05	0.000159	CbGpPWpGaD
Imatinib—PDGFRA—Disease—BAD—adrenal gland cancer	4.34e-05	0.000158	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PRKACA—adrenal gland cancer	4.3e-05	0.000157	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IGF1R—adrenal gland cancer	4.29e-05	0.000156	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—RRM1—adrenal gland cancer	4.27e-05	0.000156	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SDHD—adrenal gland cancer	4.27e-05	0.000156	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—EGFR—adrenal gland cancer	4.27e-05	0.000156	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	4.26e-05	0.000156	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	4.26e-05	0.000155	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—BAD—adrenal gland cancer	4.24e-05	0.000155	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MED12—adrenal gland cancer	4.22e-05	0.000154	CbGpPWpGaD
Imatinib—CA1—Metabolism—PTGS2—adrenal gland cancer	4.21e-05	0.000154	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—EGFR—adrenal gland cancer	4.21e-05	0.000154	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IGF2—adrenal gland cancer	4.2e-05	0.000153	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—EGFR—adrenal gland cancer	4.18e-05	0.000153	CbGpPWpGaD
Imatinib—KIT—Disease—BRAF—adrenal gland cancer	4.17e-05	0.000152	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.17e-05	0.000152	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—GNAS—adrenal gland cancer	4.16e-05	0.000152	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PRKACA—adrenal gland cancer	4.13e-05	0.000151	CbGpPWpGaD
Imatinib—ABL1—Immune System—BAD—adrenal gland cancer	4.13e-05	0.000151	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	4.09e-05	0.000149	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IGF1R—adrenal gland cancer	4.06e-05	0.000148	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—EGFR—adrenal gland cancer	4.04e-05	0.000147	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—POMC—adrenal gland cancer	4.04e-05	0.000147	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.04e-05	0.000147	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—RRM1—adrenal gland cancer	4.03e-05	0.000147	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SDHD—adrenal gland cancer	4.03e-05	0.000147	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.02e-05	0.000147	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—RRM1—adrenal gland cancer	3.99e-05	0.000146	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SDHD—adrenal gland cancer	3.99e-05	0.000146	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—BRAF—adrenal gland cancer	3.99e-05	0.000146	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	3.97e-05	0.000145	CbGpPWpGaD
Imatinib—PDGFRA—Disease—BRAF—adrenal gland cancer	3.95e-05	0.000144	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CDC42—adrenal gland cancer	3.92e-05	0.000143	CbGpPWpGaD
Imatinib—PDGFRB—Disease—BAD—adrenal gland cancer	3.91e-05	0.000143	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.86e-05	0.000141	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CTNNB1—adrenal gland cancer	3.84e-05	0.00014	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—EGFR—adrenal gland cancer	3.79e-05	0.000138	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IGF2—adrenal gland cancer	3.78e-05	0.000138	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—GNAS—adrenal gland cancer	3.75e-05	0.000137	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PRKACA—adrenal gland cancer	3.71e-05	0.000135	CbGpPWpGaD
Imatinib—CA9—Metabolism—PTGS2—adrenal gland cancer	3.7e-05	0.000135	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—EGFR—adrenal gland cancer	3.69e-05	0.000135	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TERT—adrenal gland cancer	3.69e-05	0.000135	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IGF1R—adrenal gland cancer	3.66e-05	0.000133	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—EGFR—adrenal gland cancer	3.64e-05	0.000133	CbGpPWpGaD
Imatinib—ALB—Metabolism—MED12—adrenal gland cancer	3.64e-05	0.000133	CbGpPWpGaD
Imatinib—LCK—Disease—TERT—adrenal gland cancer	3.61e-05	0.000132	CbGpPWpGaD
Imatinib—PDGFRB—Disease—BRAF—adrenal gland cancer	3.56e-05	0.00013	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TERT—adrenal gland cancer	3.49e-05	0.000128	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GNAS—adrenal gland cancer	3.49e-05	0.000127	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GNAS—adrenal gland cancer	3.45e-05	0.000126	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GNAS—adrenal gland cancer	3.45e-05	0.000126	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—adrenal gland cancer	3.44e-05	0.000126	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ABCB1—adrenal gland cancer	3.42e-05	0.000125	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—RRM1—adrenal gland cancer	3.41e-05	0.000125	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SDHD—adrenal gland cancer	3.41e-05	0.000125	CbGpPWpGaD
Imatinib—LCK—Immune System—BAD—adrenal gland cancer	3.4e-05	0.000124	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	3.39e-05	0.000124	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	3.39e-05	0.000124	CbGpPWpGaD
Imatinib—KIT—Disease—PTGS2—adrenal gland cancer	3.37e-05	0.000123	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GNAS—adrenal gland cancer	3.35e-05	0.000122	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ABCB1—adrenal gland cancer	3.29e-05	0.00012	CbGpPWpGaD
Imatinib—KIT—Immune System—CTNNB1—adrenal gland cancer	3.27e-05	0.000119	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MED12—adrenal gland cancer	3.27e-05	0.000119	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.25e-05	0.000119	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.24e-05	0.000118	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GNAS—adrenal gland cancer	3.22e-05	0.000117	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—BAD—adrenal gland cancer	3.21e-05	0.000117	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—adrenal gland cancer	3.19e-05	0.000116	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MED12—adrenal gland cancer	3.19e-05	0.000116	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	3.16e-05	0.000115	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CDC42—adrenal gland cancer	3.15e-05	0.000115	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TERT—adrenal gland cancer	3.15e-05	0.000115	CbGpPWpGaD
Imatinib—LCK—Disease—BAD—adrenal gland cancer	3.14e-05	0.000115	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CTNNB1—adrenal gland cancer	3.09e-05	0.000113	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	3.08e-05	0.000112	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—EGFR—adrenal gland cancer	3.04e-05	0.000111	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—BAD—adrenal gland cancer	3.04e-05	0.000111	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IGF2—adrenal gland cancer	3.03e-05	0.000111	CbGpPWpGaD
Imatinib—KIT—Disease—CTNNB1—adrenal gland cancer	3.02e-05	0.00011	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—GNAS—adrenal gland cancer	3.01e-05	0.00011	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MED12—adrenal gland cancer	3e-05	0.00011	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MED12—adrenal gland cancer	2.98e-05	0.000109	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—POMC—adrenal gland cancer	2.96e-05	0.000108	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IGF1R—adrenal gland cancer	2.93e-05	0.000107	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—BRAF—adrenal gland cancer	2.92e-05	0.000107	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—EGFR—adrenal gland cancer	2.92e-05	0.000107	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.92e-05	0.000107	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.88e-05	0.000105	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—adrenal gland cancer	2.88e-05	0.000105	CbGpPWpGaD
Imatinib—LCK—Disease—BRAF—adrenal gland cancer	2.86e-05	0.000104	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CTNNB1—adrenal gland cancer	2.86e-05	0.000104	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—adrenal gland cancer	2.84e-05	0.000104	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—POMC—adrenal gland cancer	2.8e-05	0.000102	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CTNNB1—adrenal gland cancer	2.79e-05	0.000102	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—BRAF—adrenal gland cancer	2.77e-05	0.000101	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—BAD—adrenal gland cancer	2.74e-05	9.99e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CTNNB1—adrenal gland cancer	2.72e-05	9.91e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.66e-05	9.71e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PRKACA—adrenal gland cancer	2.65e-05	9.68e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.63e-05	9.61e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.63e-05	9.61e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.59e-05	9.47e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—EGFR—adrenal gland cancer	2.59e-05	9.45e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CTNNB1—adrenal gland cancer	2.57e-05	9.39e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MED12—adrenal gland cancer	2.54e-05	9.29e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TERT—adrenal gland cancer	2.53e-05	9.22e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—POMC—adrenal gland cancer	2.52e-05	9.21e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GNAS—adrenal gland cancer	2.5e-05	9.11e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—BRAF—adrenal gland cancer	2.49e-05	9.1e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	2.45e-05	8.94e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EGFR—adrenal gland cancer	2.45e-05	8.94e-05	CbGpPWpGaD
Imatinib—KIT—Disease—EGFR—adrenal gland cancer	2.39e-05	8.72e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.38e-05	8.69e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—POMC—adrenal gland cancer	2.35e-05	8.57e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.33e-05	8.5e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—POMC—adrenal gland cancer	2.33e-05	8.49e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.33e-05	8.49e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—POMC—adrenal gland cancer	2.32e-05	8.48e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—adrenal gland cancer	2.31e-05	8.42e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EGFR—adrenal gland cancer	2.28e-05	8.34e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.27e-05	8.3e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EGFR—adrenal gland cancer	2.26e-05	8.26e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—POMC—adrenal gland cancer	2.25e-05	8.23e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CTNNB1—adrenal gland cancer	2.24e-05	8.16e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EGFR—adrenal gland cancer	2.21e-05	8.06e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—BAD—adrenal gland cancer	2.2e-05	8.02e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.19e-05	8e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.17e-05	7.93e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—POMC—adrenal gland cancer	2.16e-05	7.9e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—EGFR—adrenal gland cancer	2.15e-05	7.85e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GNAS—adrenal gland cancer	2.15e-05	7.85e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.12e-05	7.75e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CTNNB1—adrenal gland cancer	2.11e-05	7.71e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCB1—adrenal gland cancer	2.11e-05	7.7e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CTNNB1—adrenal gland cancer	2.06e-05	7.53e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EGFR—adrenal gland cancer	2.04e-05	7.44e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—POMC—adrenal gland cancer	2.03e-05	7.39e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—BRAF—adrenal gland cancer	2e-05	7.3e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CTNNB1—adrenal gland cancer	2e-05	7.3e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.96e-05	7.17e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.93e-05	7.05e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—adrenal gland cancer	1.92e-05	7e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.89e-05	6.91e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.88e-05	6.88e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.87e-05	6.83e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.86e-05	6.77e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.86e-05	6.77e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	1.85e-05	6.76e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.81e-05	6.62e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CTNNB1—adrenal gland cancer	1.8e-05	6.57e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—adrenal gland cancer	1.8e-05	6.56e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.78e-05	6.48e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—EGFR—adrenal gland cancer	1.77e-05	6.47e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.76e-05	6.42e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.74e-05	6.36e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.73e-05	6.3e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	1.73e-05	6.3e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—adrenal gland cancer	1.7e-05	6.19e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.68e-05	6.14e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EGFR—adrenal gland cancer	1.67e-05	6.11e-05	CbGpPWpGaD
Imatinib—LCK—Disease—EGFR—adrenal gland cancer	1.64e-05	5.97e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EGFR—adrenal gland cancer	1.58e-05	5.78e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.5e-05	5.49e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.48e-05	5.39e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—POMC—adrenal gland cancer	1.45e-05	5.29e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CTNNB1—adrenal gland cancer	1.45e-05	5.28e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.43e-05	5.23e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EGFR—adrenal gland cancer	1.43e-05	5.21e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—adrenal gland cancer	1.41e-05	5.13e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.34e-05	4.89e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—adrenal gland cancer	1.33e-05	4.85e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.3e-05	4.74e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—POMC—adrenal gland cancer	1.27e-05	4.63e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—adrenal gland cancer	1.2e-05	4.37e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.2e-05	4.36e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.19e-05	4.33e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.16e-05	4.24e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	4.22e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EGFR—adrenal gland cancer	1.15e-05	4.18e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.14e-05	4.16e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.04e-05	3.78e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.01e-05	3.7e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.01e-05	3.69e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—adrenal gland cancer	9.62e-06	3.51e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.54e-06	3.48e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	9.45e-06	3.45e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	8.08e-06	2.95e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.82e-06	2.85e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.24e-06	2.28e-05	CbGpPWpGaD
